Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways. [electronic resource]
Producer: 20151028Description: 5511 p. digitalISSN:- 2045-2322
- Antineoplastic Agents -- administration & dosage
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cisplatin -- administration & dosage
- Dose-Response Relationship, Drug
- Humans
- Immediate-Early Proteins -- metabolism
- Male
- Prostatic Neoplasms -- drug therapy
- Protein Serine-Threonine Kinases -- metabolism
- Signal Transduction -- drug effects
- Treatment Outcome
- Tumor Suppressor Protein p53 -- metabolism
- Tumor Suppressor Proteins -- metabolism
- NF-kappaB-Inducing Kinase
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.